Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Shares Issued (2016 - 2025)

Traws Pharma's Shares Issued history spans 14 years, with the latest figure at -$3.5 million for Q4 2025.

  • Quarterly results put Shares Issued at -$3.5 million for Q4 2025, down 158.03% from a year ago — trailing twelve months through Dec 2025 was $26000.0 (down 99.63% YoY), and the annual figure for FY2025 was $26000.0, down 99.87%.
  • Shares Issued for Q4 2025 was -$3.5 million at Traws Pharma, down from $3.5 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $6.0 million in Q4 2024 to a low of -$3.5 million in Q4 2025.
  • The 5-year median for Shares Issued is $500000.0 (2021), against an average of $709571.4.
  • The sharpest move saw Shares Issued skyrocketed 1100.0% in 2022, then plummeted 158.03% in 2025.
  • Year by year, Shares Issued stood at -$50000.0 in 2021, then skyrocketed by 1100.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then skyrocketed by 1095.6% to $6.0 million in 2024, then plummeted by 158.03% to -$3.5 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$3.5 million, $3.5 million, and $2000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.